Presentation is loading. Please wait.

Presentation is loading. Please wait.

Strategies for Combatting After-Meal Highs Gary Scheiner MS, CDE

Similar presentations


Presentation on theme: "Strategies for Combatting After-Meal Highs Gary Scheiner MS, CDE"— Presentation transcript:

1 Strategies for Combatting After-Meal Highs Gary Scheiner MS, CDE
Strike The Spike! Strategies for Combatting After-Meal Highs Gary Scheiner MS, CDE

2 Overview Definitions Risks Detection Management

3 After-Meal Peaks Defined
The net rise that occurs from before eating to the highest point after eating. ADA Goal: <180 mg/dl 1-2 hrs after start of meal AACE Target: <140 at peak European Diabetes Policy Group: <165 (to prevent complications) International Diabetes Federation: < 140 mg/dl 2 hrs after meal

4 After-Meal Goals for Children
Under 5 Years: 1 hr. post-meal (<120 pt. Rise) 5-11 Years: 1 hr. post-meal (<100 pt. Rise) 12 Years + < 1 hr. post-meal (<80 pt. Rise)

5 After-Meal Peaks: Reality for children
Source: Boland et al, Diabetes Care 24: 1858, 2001

6 After-Meal Peaks: Reality in Children
Source: Boland et al, Diabetes Care 24: 1858, 2001

7 After-Meal Highs: Immediate Problems
Tiredness Difficulty Concentrating Impaired Athletic Performance Decreased desire to move Mood Shifts Enhanced Hunger

8 After-Meal Highs: Immediate Problems
Australian Study of Children w/Type 1. Parents & children reported BG > 270 had negative impact on: Thinking (68%) Mood/Emotions (75%) Coordination (53%) J Pediatr Endocrinol Metab Jul;19(7);

9 Long-Term Problems Relative Influence on HbA1c
Source: Monnier et al, Diabetes Care, 26, 3/03,

10 Long-Term Problems (contd)
52 Type 1’s, similar BP between groups Post-prandial glucose Range Time to onset of proteinuria Persistent <200 23 yrs Intermittent >200 19 yrs Persistent > 200 201 + 14 yrs Source: Kidney Intl. 1987; 32 (supp 22): S53-S56

11 Long-Term Problems (contd)
22-yr CVD Mortality Risk by Baseline post-challenge glucose Source: Chicago Heart Study, Lowe et al, Diabetes Care, 1997; 20:

12 Long-Term Problems (contd)
Rates of eye and kidney disease based on glucose variability (using CGM) in Type-2 Diabetes Source: Liu et al, American Diabetes Association 71st Scientific Sessions 2011, Abstract 2205-PO.

13

14 Measurement of After-Meal Peaks
SMBG Capillary (finger) test After completion of meal Check BG 1 Hr PP (or) every 15, 20 or 30 min until 2 consecutive BG drops occur No addl. Food/insulin until test is completed

15 Meter Test Example Brea kfast Lun ch Din ner Pre 1h Post 117 281 157
166 191 204 90 302 58 247 89 147 151 264 77 152 235 222 Interpretation: Excessive after-meal peak following breakfast; not after lunch or dinner

16 Meter Test Example Time pp BG Value Interpretation: Premeal 135
: : 1: 1: 1: 2: Interpretation: Peak occurred at 1hr, 20min pp; rise from premeal to peak was approx. 90 mg/dl

17 Measurement of After-Meal Peaks
iPro (Medtronic) Worn for 72 hrs, then data is downloaded BG data every 5 minutes Analysis software shows post-meal patterns

18 Measurement of After-Meal Peaks
Real-Time Continuous Glucose Monitors Allow tracking of post-meal trends Produce BG estimates every 5 minutes

19 CGMS Case Study 37 year old man

20 CGMS Case Study 8 year old girl

21 CGMS Case Studies 12 year old boy

22 After-Meal Spike Reduction
Lifestyle Approaches Medicinal Approaches

23 Glycemic Index All carbs (except fiber) convert to blood glucose eventually G.I. Reflects the magnitude of blood glucose rise for the first 2 hours following ingestion G.I. Number is % or rise relative to pure glucose (100% of glucose is in bloodstream within 2 hours)

24 Glycemic Index (contd.)
Example: Spaghetti GI = 37 Only 37% of spaghetti’s carbs turn into blood glucose in the first 2 hours. The rest will convert to blood glucose over the next several hours.

25 Glycemic Index (contd)

26 Glycemic Index (contd)
Use of Glycemic Index Lower GI foods digest & convert to glucose more slowly High-fiber slower than low Hi-fat slower than low Solids slower than liquids Cold foods slower than hot Type of sugar/starch affects GI

27 Glycemic Index (contd.)
Slow Stuff Average Stuff Fast Stuff Pasta Legumes Salad Veggies Dairy Chocolate Fruit Juice Pizza Soup Cake Breads/Crackers Salty Snacks Potatoes Rice Cereals Sugary Candies

28 Examples: Use of GI   Meal High-GI Options Low-GI Options Breakfast
  Examples: Use of GI Meal High-GI Options Low-GI Options Breakfast Cereal, Bagel, Waffle, Pancakes, Muffins Oatmeal, Milk, Whole Fruit Lunch White Bread, Fries, Tortillas, Cupcake Sourdough/Pumpernickel, Yogurt, Corn, Carrots Snacks Pretzels, Chips, Crackers, Doughnuts Fruit, Popcorn, Nuts, Ice Cream, Chocolate Dinner Rice, Mashed or Baked Potatoes, Rolls Pasta, Peas, Beans, Sweet Potato, Salad Veggies

29 Add Some Acidity 60-min glucose response 55%*
Tomatoes Sourdough Vinegar (Salad Dressing/Condiments) *Journal of the American Dietetic Association, 2005: v7 no12.

30 Split The Meal  Part at the usual mealtime  Part minutes later

31 Choice of Bolus Insulin
Humalog Novolog or Apidra Vs. Regular Insulin 1-hr. peak 3-4 hr. effective duration 2-3 hr. peak 4-6 hr. effective duration

32 Timing of Bolus Insulin

33 Timing of Bolus Insulin
(humalog/novolog) High GI Moderate GI Low GI BG Above Target Range 30-40 min. prior 15-20 min. prior 0-5 min. prior BG Within Target Range 15-20 min. after BG Below Target Range 30-40 min. after

34 Does Timing Matter? Note: Carbs estimated w/pre-meal insulin.
Carbs known with post-meal insulin. Source: Clinical Therapeutics 2004; 26:

35 Does Timing Matter? Bolus w/meal Bolus pre-meal

36 Choice of Insulin Program
Lantus & MDI Vs. Daytime NPH/Lente Meal/snack boluses Prolonged peak covers midday meals/snacks

37 Injectible Symlin (Amylin Pharmaceuticals)
Acts on CNS  Appetite Slows gastric emptying Inhibits glucagon secretion Really flattens postprandial BGs

38 Injectible Symlin ( Pharmaceuticals)
 Well-tolerated in adolescents  4-week A1c decrease of .84  Slight weight decrease (<1 lb) No observed DKA or severe hypoglycemia (w/careful dose titration) Chase, et al, and Burdick, et al. Diabetes, June 2008, V57 suppl. 1, 1802-P and 1803-P.

39 Injectible Symlin (Amylin Pharmaceuticals)
Issues Nausea Must be injected*, cannot mix w/insulin Insulin doses must be adjusted, delayed Not yet FDA approved for children * pumped???

40 Effect of Pramlintide on Gastric Emptying in Type 1 Diabetes
Breakfast Insulin + Placebo Insulin + Pramlintide 4 * * ~1-h delay 3 DISCUSSION POINTS: Pramlintide slows gastric emptying of the solid portion of a standard meal in subjects with type 1 diabetes. Gastric emptying is the rate-limiting step that regulates glucose delivery from the GI tract into the bloodstream. The effects of pramlintide, seen at the first meal, were no longer present at a subsequent meal. SLIDE BACKGROUND: Double-blind, randomized, crossover study (n = 11 males with type 1 diabetes). Participants self-injected their usual dose of insulin and 15 min later, self-injected either placebo, 30 µg pramlintide, or 60 µg pramlintide prior to the first of 2 meals issued. Study participants then ate a standard meal (a radio-labeled pancake and milkshake). Radio images of the stomach were obtained for the next 8 h. Data presented are mean  SEM. Mean Half-Emptying Time (h) 2 1 Placebo 30 µg 60 µg Single SC pramlintide doses: n = 11, crossover; *P<0.004; 99m Tc labelled pancake; solid component measured Data from Kong MF, et al. Diabetologia 1998; 41:

41 Pramlintide Reduces Postprandial Glucagon
Type 2 Diabetes, Late Stage Type 1 Diabetes Placebo Pramlintide Insulin Insulin Sustacal® 30 Sustacal® 60 20 DISCUSSION POINTS: Pramlintide reduces postprandial glucagon secretion in insulin-using patients with both type 2 and type 1 diabetes. This slide demonstrates the effect of intravenous infusion of pramlintide on postprandial glucagon in 2 separate studies involving insulin-using patients with type 2 diabetes (left figure) and type 1 (right figure) diabetes. SLIDE BACKGROUND: Left figure: Crossover design study; insulin-treated patients with type 2 diabetes (n = 12) were infused with either pramlintide (100 g/h) or placebo for 5 h during a SUSTACAL® meal challenge test. Right figure: Crossover study design; patients with type 1 diabetes (n = 9) infused with pramlintide (25 g/h) or placebo for 5 h during a SUSTACAL® meal challenge test. In both studies, pramlintide or placebo was infused at t = 0 min, regular insulin injected at t = 30 min, and SUSTACAL® meal ingested at t = 60 min. Data presented are mean ( SE) plasma glucagon (pg/mL). A similar study, conducted in non-insulin-using patients with type 2 diabetes, yielded similar results. SUSTACAL® is a registered trademark of Mead Johnson. 50 10 Plasma Glucagon (pg/mL)  Plasma Glucagon (pg/mL) 40 -10 30 Placebo or 100 µg/h pramlintide infusion 1 2 3 4 5 Placebo or 25 µg/h pramlintide infusion -20 1 2 3 4 5 Time (h) Time (h) Type 2 diabetes, n = 12; AUC1-4 h: P = 0.005 Type 1 diabetes, n = 9; AUC1-5 h: P<0.001; Data from: Fineman M, et al. Metabolism 2002; 51: ; Fineman M, et al. Horm Metab Res 2002; 34:

42 Pramlintide Reduces Caloric Intake in Type 2 Diabetes
1250 -202 kcal (-23%) P <0.01 Placebo Pramlintide 1000 DISCUSSION POINTS: Pramlintide reduced mean caloric intake and macronutrient intake during a buffet study in subjects with type 2 diabetes. SLIDE BACKGROUND: In a randomized, double-blind, placebo (PBO)-controlled, crossover study, subjects underwent a standardized buffet meal test on 2 occasions. After an overnight fast, subjects received a single SC injection of pramlintide (120 g) or PBO, immediately followed by a standardized preload meal. After 1 h, subjects were offered an ad-libitum buffet meal. Total caloric intake (TCI) and meal duration were measured. 750 CHO Ad-Libitum Caloric Intake (kcal) CHO 500 Fat Fat 250 Protein Protein n = 11; subjects given buffet meal Pramlintide (single SC injection, 120 g) Data from Chapman I, et al. Diabetologia 2005; 48:

43 Pre-Meal Hypoglycemia
“Sieve Effect” Accelerates gastric emptying of liquids and solids Produces more rapid BG rise after meal J Clin Endo Metab 2005; 90: A v o i d P r e – M e a l L o w s !

44 Physical Activity Intervention
Muscle Use Soon After Eating Accelerated Delayed Glucose Uptake/ Insulin Absorption Digestion Utilization Improved After-Meal Control

45 Examples: After-Meal/Snack Activity
Walking Pets Household Chores Planned Exercise Yard Work Gym Class??? Shooting Hoops Dancing Bowling Mini Golf Skating

46 Examples: After-Meal/Snack Activity
“Free Time With Siblings”

47 Summary After-Meal Blood Sugar Levels Are: Important to Control
Measurable Manageable

48 For More Information: Gary Scheiner MS, CDE
Integrated Diabetes Services (877-SELF-MGT) Website:


Download ppt "Strategies for Combatting After-Meal Highs Gary Scheiner MS, CDE"

Similar presentations


Ads by Google